Quince Therapeutics (NASDAQ:QNCX) Shares Up 2.6%

Shares of Quince Therapeutics, Inc. (NASDAQ:QNCXGet Rating) rose 2.6% during trading on Tuesday . The company traded as high as $0.76 and last traded at $0.73. Approximately 280,818 shares were traded during mid-day trading, a decline of 41% from the average daily volume of 479,653 shares. The stock had previously closed at $0.71.

Quince Therapeutics Stock Performance

The company has a fifty day simple moving average of $1.05.

About Quince Therapeutics

(Get Rating)

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease.

Featured Stories

Receive News & Ratings for Quince Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quince Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.